Keywords: Rx-to-OTC switching, USA, Pfizer, Lipitor, Francesco International

$30 billion of fresh opportunities for Rx-to-OTC switch in USA

Article | 19 February 2013

Print This

The US Food and Drug Administration has recently created the Non-prescription Safe Use Regulatory Expansion (NSURE) task force and is ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in